Ottimo Pharma
PrivateLast Round
Series A
Dec 19, 2024
Total Funding Raised
$140M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Ottimo Pharma operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Series A round in December 2024.
Ottimo Pharma is a biotechnology company that develops pioneering bi-functional medicines and cancer therapies for solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ottimo Pharma Comparables
Compare Ottimo Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Crescent Biopharma | 82% | |
| Akeso, Inc. | 81% | |
| Summit Therapeutics Inc. | 80% |
For institutional investors. Book with your work email.
Ottimo Pharma Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Ottimo Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | Series A |
| Avoro Capital | Series A |
| OrbiMed | Series A |
| Invus Opportunities | Series A |
| J.P. Morgan Life Sciences Private Capital | Series A |
| RTW Investments | Series A |
| Samsara BioCapital | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 682% MoM.
- Aug 27, 2025
Partnered with Asimov for cell line development.
For institutional investors. Book with your work email.
Ottimo Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ottimo Pharma's valuation, stock price, and market status.
Is Ottimo Pharma a public or private company?
Ottimo Pharma is a private company.
What is the current stock price of Ottimo Pharma?
Ottimo Pharma is a private company, so its shares have no public market price. Caplight tracks Ottimo Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ottimo Pharma worth (valuation)?
Valuation information for Ottimo Pharma is not publicly available.
Can I buy Ottimo Pharma stock?
Ottimo Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ottimo Pharma's last funding round?
Ottimo Pharma's most recent funding round was Series A on December 19, 2024.
Who are the main investors in Ottimo Pharma?
Key investors in Ottimo Pharma include Avoro Capital, OrbiMed, Samsara BioCapital.
Will Ottimo Pharma IPO soon?
No public IPO plans have been announced for Ottimo Pharma.
How can I track Ottimo Pharma secondary market activity?
Caplight tracks bids, offers, and trades in Ottimo Pharma's shares on secondary markets.